[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Kleinschmidt
R
R
Spannbrucker
N
N
Vogel
F
F
D002395:Catecholamines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004280:Dobutamine / Q000627:therapeutic use*; D004298:Dopamine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012079:Renal Circulation / Q000187:drug effects; D012770:Shock, Cardiogenic / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D004280:Dobutamine; D004298:Dopamine
Die Kombination von Dopamin und Dobutamin in der Differentialtherapie der akuten und chronischen Myokardinsuffizienz.